FDA Drug Application (071891) for SULINDAC by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number071891
Product Number001
FormTABLET;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSULINDAC
Active IngredientSULINDAC

Active IngredientCount
List of drugs with Active Ingredient SULINDAC2


Back to FDA Applications sponsored by WATSON LABS